Abstract
The Venovo (Bard; Tempe, AZ), Vici (Boston Scientific; Marlborough, MA), Zilver Vena (Cook Medical Inc., Bloomington, IN), and Abre (Medtronic; Minneapolis, MN) stents have recently been FDA approved for use in the iliofemoral venous system although the use of Venovo has been halted and Vici recalled at present. In this case series, we present the off-label use of these stents in the central thoracic veins.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
